Home / Recalls / Prestige Brands Holdings / D-0766-2026

D-0766-2026 Class II Ongoing

Recalled by Prestige Brands Holdings — Tarrytown, NY

FDA drug recall D-0766-2026 was initiated by Prestige Brands Holdings on Jul 29, 2026 and is designated Class II. Reason for recall: Lack of assurance of sterility. The recall is due to potential contamination The recall status is ongoing. Affected quantity: 39,060 15mL-bottles.

Recall Details

Product Type: Drugs
Report Date: Aug 19, 2026
Initiation Date: Jul 29, 2026
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 39,060 15mL-bottles

Product Description

CLEAR EYES Maximum Itchy Eye Relief, 0.5 fl oz (15 mL) per dropper bottle, Sterile, Dist. by Medtech Products Inc., Tarrytown, NY 10591, a Prestige Consumer Healthcare Company. NDC: 67172-999-01 UPC 6 78112 65920 3

Reason for Recall

Lack of assurance of sterility. The recall is due to potential contamination

Distribution Pattern

Nationwide in the USA.

Code Information

Lot 2552A, Exp 09/30/2027

Source

Dataset: openFDA drug recall enforcement reports
FDA record: This recall in openFDA (JSON)
Enforcement Report: Search FDA's Enforcement Report for D-0766-2026
openFDA file date: Nov 10, 2026
Loaded by RegDataLab: Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.